- Type / Class
- Equity / Common Stock
- Shares outstanding
- 164,426,217
- Total 13F shares
- 59,189,838
- Share change
- +4,562,060
- Total reported value
- $665,851,766
- Put/Call ratio
- 408%
- Price per share
- $11.25
- Number of holders
- 117
- Value change
- +$50,911,029
- Number of buys
- 72
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 26818M108?
CUSIP 26818M108 identifies DYN - Dyne Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 26818M108:
Top shareholders of DYN - Dyne Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6%
|
9,885,449
|
$113,880,372 | — | 31 Mar 2023 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
3%
|
4,951,303
|
$57,039,011 | — | 31 Mar 2023 | |
| Atlas Venture Opportunity Fund II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,543,366
|
$44,508,906 | — | 12 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
3,028,800
|
$34,891,776 | — | 31 Mar 2023 | |
| WASATCH ADVISORS LP |
13F
|
Company |
1.8%
|
2,927,278
|
$33,722,243 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
2,619,221
|
$30,173,428 | — | 31 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
1.4%
|
2,334,633
|
$26,894,972 | — | 31 Mar 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.4%
|
2,322,384
|
$26,753,864 | — | 31 Mar 2023 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
1.4%
|
2,220,034
|
$25,574,792 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
1,892,359
|
$21,799,976 | — | 31 Mar 2023 | |
| Logos Global Management LP |
13F
|
Company |
1%
|
1,700,000
|
$19,584,000 | — | 31 Mar 2023 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1%
|
1,650,150
|
$19,009,728 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
1,494,450
|
$17,216,064 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.88%
|
1,446,757
|
$16,666,641 | — | 31 Mar 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.84%
|
1,377,872
|
$15,873,085 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.56%
|
921,135
|
$10,611,473 | — | 31 Mar 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.42%
|
692,945
|
$7,982,726 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.4%
|
660,630
|
$7,610,616 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.37%
|
600,812
|
$6,921,354 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
600,000
|
$6,912,000 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.39%
|
633,624
|
$6,718,531 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.35%
|
578,851
|
$6,668,364 | — | 31 Mar 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
0.35%
|
577,642
|
$6,654,436 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
568,522
|
$6,549,373 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
532,609
|
$6,136,000 | — | 31 Mar 2023 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.29%
|
478,401
|
$5,511,180 | — | 31 Mar 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.26%
|
433,751
|
$4,988,137 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.26%
|
424,113
|
$4,885,782 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.25%
|
409,056
|
$4,712,325 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.22%
|
363,600
|
$4,188,672 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.2%
|
328,112
|
$3,779,850 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.18%
|
291,310
|
$3,357,000 | — | 31 Mar 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.17%
|
275,164
|
$3,169,889 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
274,473
|
$3,161,929 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.16%
|
263,196
|
$3,032,018 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.15%
|
240,894
|
$2,775,099 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
236,500
|
$2,724,480 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.14%
|
228,821
|
$2,636,018 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
227,584
|
$2,621,768 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.14%
|
226,626
|
$2,610,732 | — | 31 Mar 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.13%
|
219,316
|
$2,526,520 | — | 31 Mar 2023 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.12%
|
191,872
|
$2,210,000 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
190,363
|
$2,193,000 | — | 31 Mar 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.11%
|
178,901
|
$2,060,940 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.11%
|
176,601
|
$2,034,444 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.1%
|
158,987
|
$1,831,530 | — | 31 Mar 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.09%
|
155,000
|
$1,785,600 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
134,613
|
$1,550,000 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
132,344
|
$1,524,603 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
126,863
|
$1,461,462 | — | 31 Mar 2023 |
Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q2 2023
As of 30 Jun 2023,
Dyne Therapeutics, Inc. - Common Stock (DYN) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,189,838 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, MPM ASSET MANAGEMENT LLC, BlackRock Inc., CITADEL ADVISORS LLC, Deep Track Capital, LP, VANGUARD GROUP INC, WASATCH ADVISORS LP, Vida Ventures Advisors, LLC, VR Adviser, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
125
Q2 2023 holders
117
Holder diff
-8
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.